BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10583084)

  • 1. Cutaneous relapse in acute promyelocytic leukaemia following treatment with all-trans retinoic acid.
    Chang SE; Huh J; Choi JH; Sung KJ; Moon KC; Koh JK
    Br J Dermatol; 1999 Sep; 141(3):586-7. PubMed ID: 10583084
    [No Abstract]   [Full Text] [Related]  

  • 2. Central nervous system relapse in acute promyelocytic leukaemia treated with all-trans retinoic acid.
    Seldon M; Enno A
    Aust N Z J Med; 1998 Aug; 28(4):462. PubMed ID: 9777115
    [No Abstract]   [Full Text] [Related]  

  • 3. All-trans retinoic acid in the treatment of acute promyelocytic leukaemia.
    White KL; Wiley JS; Frost T; McKendrick JJ; Hermann RP; Seldon M; Enno A; Bell R; Bunce I; Taylor K
    Aust N Z J Med; 1992 Oct; 22(5):449-54. PubMed ID: 1445034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypercalcaemia caused by all-trans retinoic acid treatment of acute promyelocytic leukaemia: case report.
    Suzumiya J; Asahara F; Katakami H; Kimuran N; Hisano S; Okumura M; Ohno R
    Eur J Haematol; 1994 Aug; 53(2):126-7. PubMed ID: 8088385
    [No Abstract]   [Full Text] [Related]  

  • 5. In vivo evidence of all-trans retinoic acid inducing maturation in acute promyelocytic leukaemia.
    Hamidah HN; Cheong SK; Ainoon O
    Acta Haematol; 1993; 89(1):50-1. PubMed ID: 8480488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meningeal relapse in a patient with acute promyelocytic leukaemia treated with all-trans retinoic acid.
    Martino B; Vincelli I; Marino A; Comis M; Ronco F; Nobile F
    Br J Haematol; 1998 Mar; 100(3):606-7. PubMed ID: 9504652
    [No Abstract]   [Full Text] [Related]  

  • 7. Retinoic acid syndrome induced by arsenic trioxide in treating recurrent all-trans retinoic acid resistant acute promyelocytic leukemia.
    Che-Pin Lin ; Huang MJ; Chang IY; Lin WY; Sheu YT
    Leuk Lymphoma; 2000 Jun; 38(1-2):195-8. PubMed ID: 10811463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central nervous system relapse in acute promyelocytic leukaemia in patients treated with all-trans retinoic acid.
    Evans G; Grimwade D; Prentice HG; Simpson N
    Br J Haematol; 1997 Aug; 98(2):437-9. PubMed ID: 9266945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of first relapse in acute promyelocytic leukaemia with all-trans retinoic acid.
    Degos L; Chomienne C; Daniel MT; Berger R; Dombret H; Fenaux P; Castaigne S
    Lancet; 1990 Dec; 336(8728):1440-1. PubMed ID: 1978887
    [No Abstract]   [Full Text] [Related]  

  • 10. Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: a report by the Gruppo Italiano Malattie Ematologiche dell'Adulto.
    Specchia G; Lo Coco F; Vignetti M; Avvisati G; Fazi P; Albano F; Di Raimondo F; Martino B; Ferrara F; Selleri C; Liso V; Mandelli F
    J Clin Oncol; 2001 Oct; 19(20):4023-8. PubMed ID: 11600603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary leukostasis secondary to all-trans retinoic acid in the treatment of acute promyelocytic leukemia in first relapse.
    Vosburgh E
    Leukemia; 1992 Jun; 6(6):608-10. PubMed ID: 1602800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2. All-trans retinoic acid in the treatment of acute promyelocytic leukemia.
    Asou N
    Intern Med; 2007; 46(2):91-3. PubMed ID: 17220606
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of all-trans-retinoic acid in the treatment of acute promyelocytic leukemia.
    Fenaux P
    Acta Haematol; 1993; 89 Suppl 1():22-7. PubMed ID: 8475669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal thromboembolism in acute promyelocytic leukaemia treated with a combination of all-trans retinoic acid and aprotonin.
    Mahendra P; Keeling DM; Hood IM; Baglin TP; Marcus RE
    Clin Lab Haematol; 1996 Mar; 18(1):51-2. PubMed ID: 9118606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoic acids in the treatment of acute promyelocytic leukemia.
    Castaigne S; Chomienne C; Daniel MT; Berger R; Miclea JM; Ballerini P; Degos L
    Nouv Rev Fr Hematol (1978); 1990; 32(1):36-8. PubMed ID: 2190178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow necrosis following ALL-trans retinoic acid therapy for acute promyelocytic leukaemia.
    Dreosti LM; Bezwoda W; Gunter K
    Leuk Lymphoma; 1994 Apr; 13(3-4):353-6. PubMed ID: 8049655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York Study.
    Frankel SR; Eardley A; Heller G; Berman E; Miller WH; Dmitrovsky E; Warrell RP
    Ann Intern Med; 1994 Feb; 120(4):278-86. PubMed ID: 8291820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The "retinoic acid syndrome" in acute promyelocytic leukemia.
    Frankel SR; Eardley A; Lauwers G; Weiss M; Warrell RP
    Ann Intern Med; 1992 Aug; 117(4):292-6. PubMed ID: 1637024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Co-operative study of all-trans retinoic acid as a differentiation induction therapy of acute promyelocytic leukemia].
    Yamada O; Hatake K; Tanimoto M; Ishiyama T; Ohno R; Shirakawa S; Horiuchi A; Tomonaga M; Ohta K
    Gan To Kagaku Ryoho; 1994 Sep; 21(12):1981-9. PubMed ID: 8085849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of acute promyelocytic leukemia with all-trans retinoic acid.
    Fenaux P; Degos L
    Leuk Res; 1991; 15(8):655-7. PubMed ID: 1895747
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.